Drugs / DCI
last change Apr 2023 re-read 2 minutes ago

DCI

Developed for
polycystic ovary syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06170463 Comparator Aug 2022 → Mar 2023 polycystic ovary syndrome Zagazig University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DCI ClinicalTrials.gov intervention name — accepted as the source's own label NCT06170463